Recent Finacing
Recent Raise
EpiVax Oncology develops personalized cancer vaccines using its Ancer in silico algorithm to select neo-epitopes from tumor and normal NGS and designs individualized synthetic long-peptide vaccines for clinical trials.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
